Biologics
Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozoraki...
March 30, 2026 | News
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and developm...
March 30, 2026 | News
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A signifi...
March 30, 2026 | News
New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell cultur...
March 30, 2026 | News
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale...
March 27, 2026 | News
Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 Alteogen Inc. (KOSDAQ: 196170) ann...
March 27, 2026 | News
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation pr...
March 27, 2026 | News
First regulatory clearance in Latin America marks a strategic milestone for regional market expansion- World's first antibiotic-free manufacturing process ...
March 27, 2026 | News
Collaboration and Ridgefield expansion unite fill-finish, device final assembly and packaging in a single U.S. location Thermo Fisher Scientific...
March 26, 2026 | News
Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III...
March 26, 2026 | News
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that it has received clearance from the Center for Drug Evaluation (CDE) of China's ...
March 26, 2026 | News
Fujitsu Limited and the Center for Quantum Information and Quantum Biology at The University of Osaka announced the development of a new technology...
March 26, 2026 | News
Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 3...
March 25, 2026 | Company results
Revenue amounted to approximately RMB2057.92 million, and gross profit amounted to approximately RMB1478.78 million, representing a year-on-year increase...
March 25, 2026 | News
Most Read
Bio Jobs
News
Editor Picks